SN-008

CAS No. 2249106-01-0

SN-008( —— )

Catalog No. M28759 CAS No. 2249106-01-0

SN-008 is a less active analog SN-011 which is a STING antagonist. SN-008 can be used as a negative control.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 126 In Stock
2MG 75 In Stock
5MG 116 In Stock
10MG 187 In Stock
25MG 432 In Stock
50MG 625 In Stock
100MG 889 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    SN-008
  • Note
    Research use only, not for human use.
  • Brief Description
    SN-008 is a less active analog SN-011 which is a STING antagonist. SN-008 can be used as a negative control.
  • Description
    SN-008 is a less active analog SN-011 which is a STING antagonist. SN-008 can be used as a negative control.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Immunology/Inflammation
  • Target
    STING
  • Recptor
    Endothelium dependent relaxation
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2249106-01-0
  • Formula Weight
    446.49
  • Molecular Formula
    C25H19FN2O3S
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (223.97 mM)
  • SMILES
    O=C(c(cc1)ccc1-c1ccccc1)Nc1cccc(NS(c(cc2)ccc2F)(=O)=O)c1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Cheng DY, DeWitt BJ, McMahon TJ, Kadowitz PJ. Comparative effects of L-NNA and alkyl esters of L-NNA on pulmonary vasodilator responses to ACh, BK, and SP. Am J Physiol. 1994 Jun;266(6 Pt 2):H2416-22.
molnova catalog
related products
  • ADU-S100

    ADU-S100 (MIW815) is a synthetic cyclic dinucleotide agonist of STING, elicits potent and durable anti-tumor immunity when administered IT in pre-clinical syngeneic tumor models.

  • diABZI-C2-NH2

    diABZI-C2-NH2 is an agonist of the interferon gene STING that modulates STING-dependent type I interferon production and can be used to study STING-mediated diseases.

  • MSA-2

    MSA-2, a potent and orally available non-nucleotide STING agonist, has EC50s of 8.3 and 24 μM for human STING isoforms WT and HAQ, respectively. MSA-2 shows antitumor activity and stimulates interferon-β secretion in tumors, induces tumor regression with durable antitumor immunity, and synergizes with anti-PD-1 in syngeneic mouse tumor models.